September 13, 2017 — Since announcing the integration of CareSelect Imaging with Epic's enterprise electronic health record (EHR), National Decision Support Co. (NDSC) has steadily expanded the reach of its CareSelect Platform into the market. Over 225 mutual clients have adopted NDSC's foundational imaging solution to power imaging stewardship initiatives and compliance with federal legislation.

Nuance Communications Inc. announced that Citizens Medical Center, a critical access hospital in rural Kansas, has completed a hospital-wide deployment of Nuance solutions to reduce transcription costs and improve physician satisfaction, productivity and efficiency. The implementation includes Dragon Medical One, eScription RH, PowerMic Mobile and the PowerShare Network.

Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from Sept. 11 – 14, 2017, applying advanced technologies and deep clinical insights to address peripheral vascular needs. With the addition of its recent acquisition, Spectranetics, Philips will for the first time highlight its expanded portfolio of interventional X-ray systems, advanced catheters for measurement and therapy, clinical informatics and services, including its Philips Azurion image-guided therapy platform, intravascular ultrasound (IVUS), Phoenix atherectomy system and Spectranetics' Stellarex drug-coated balloon.

The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) voted overwhelmingly last week to recommend new labels on gadolinium-based contrast agents (GBCAs) warning of the possibility of gadolinium retention in the body following administration. The labels will further explain that linear GBCAs carry a greater risk than macrocyclic agents, and that there is a greater risk for certain patient populations, according to Medscape.